Important Clarification & Product Assessment (English):

The product name "DIAMPA M XR 12.5+1000mg Tablets" is not a dapagliflozin-based medication, despite the "DIAMPA" brand name. This is because:

1. ✅ Dapagliflozin is only approved in 5mg and 10mg doses globally.
2. ❌ 12.5mg is not a valid or approved strength for dapagliflozin—such a dose does not exist.

In Pakistan, the notation "12.5" in antidiabetic combination brands follows a common local marketing convention, where:

"12.5" = Glimepiride 2mg + Metformin 1000mg

(i.e., “2” from glimepiride + “1000” metformin → informally coded as “12.5”)

This naming pattern is widely used by pharmaceutical companies in Pakistan for fixed-dose combinations of glimepiride and metformin, even when branded under names typically associated with newer agents (like "DIAMPA").

Confirmed Likely Composition:

✅ Active Ingredients:

1. Glimepiride 2mg
2. Metformin Hydrochloride Extended-Release (XR) 1000mg

This is a standard dual-combination therapy for type 2 diabetes, with the XR formulation reducing gastrointestinal side effects.

📌 Note: The "DIAMPA M XR" name may be a brand variant, but the active ingredients are not dapagliflozin-based. Always verify the label.

Product Full Description (English):

Uses:

1. Treatment of type 2 diabetes mellitus in adults not adequately controlled with monotherapy
2. Simplified dual therapy to improve adherence and glycemic control

Key Benefits:

1. Glimepiride: Stimulates insulin secretion from pancreatic beta cells
2. Metformin XR: Reduces liver glucose production with fewer GI side effects vs. immediate-release
3. Once-daily dosing (typically with evening meal) for convenience
4. Cost-effective and well-established regimen

How To Use:

Take one tablet once daily with the evening meal to reduce hypoglycemia risk and GI upset. Swallow whole—do not crush or chew.

When Not to Use:

1. Type 1 diabetes or diabetic ketoacidosis
2. Severe renal impairment (eGFR <30 mL/min)
3. Hypersensitivity to sulfonylureas or metformin
4. Acute alcohol intoxication, liver disease, or metabolic acidosis

Side Effects:

1. Common: Hypoglycemia (sweating, tremor, dizziness, confusion), nausea, diarrhea (less with XR), metallic taste
2. Serious (rare): Lactic acidosis (muscle pain, weakness, rapid breathing), severe hypoglycemia, liver dysfunction

Dosage:

1. Typical dose: 1 tablet once daily with evening meal
2. Maximum glimepiride: usually 4–6mg/day (i.e., up to 2–3 tablets)
3. Adjust based on blood glucose and HbA1c monitoring

Warnings & Precautions:

1. Hypoglycemia risk increases with skipped meals, excessive exercise, or alcohol use
2. Avoid alcohol—increases risk of lactic acidosis and low blood sugar
3. Discontinue before iodinated contrast imaging or major surgery
4. Monitor kidney function and HbA1c regularly

Drug Interactions:

1. Alcohol: ↑ Risk of lactic acidosis and hypoglycemia
2. Beta-blockers: May mask hypoglycemia symptoms (e.g., tachycardia)
3. NSAIDs, sulfonamides, warfarin: May enhance glimepiride effect → hypoglycemia
4. Cimetidine: May increase metformin levels

Critical Recommendation:

🔍 Always check the active ingredients printed on the blister pack or box.

1. If it lists "Glimepiride 2mg + Metformin XR 1000mg", this description applies.
2. If it claims "Dapagliflozin 12.5mg", it is incorrect labeling—do not use.

In Pakistan,